Tjh
 2014
DOI: 10.4274/tjh.2013.0180
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma

Itır Şirinoğlu Demiriz1,
Emre Tekgündüz2,
Sinem Civriz Bozdağ3
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 14 publications
(17 reference statements)
0
1
0
Order By: Relevance
“…AML, ALL, MDS, CML and chronic myelomonocytic leukemia are reported secondary hematologic malignancies [19]. Until now, only one case of tAL with mixed phenotype after lymphoma has been reported [3].…”
mentioning
confidence: 99%

A Case of Therapy-Related Acute Leukemia With Mixed Phenotype With BCR-ABL1 After Treatment of Diffuse Large B-Cell Lymphoma

Yang
1
,
Cho
2
,
Jung
3
et al. 2017
Ann Lab Med
3
0
0
0
View full textAdd to dashboardCite
“…AML, ALL, MDS, CML and chronic myelomonocytic leukemia are reported secondary hematologic malignancies [19]. Until now, only one case of tAL with mixed phenotype after lymphoma has been reported [3].…”
mentioning
confidence: 99%

A Case of Therapy-Related Acute Leukemia With Mixed Phenotype With BCR-ABL1 After Treatment of Diffuse Large B-Cell Lymphoma

Yang
1
,
Cho
2
,
Jung
3
et al. 2017
Ann Lab Med
3
0
0
0
View full textAdd to dashboardCite

Sequential development of chronic myelogenous leukemia and primary myelofibrosis in a patient with history of large B-cell lymphoma treated with radiotherapy and chemotherapy: two myeloid neoplasms with distinct genotypic profiles suggestive of biclonality in a single individual

Wu
1
,
Ingersoll
2
,
Rehder
3
et al. 2016
Ann Hematol
1
0
0
0
View full textAdd to dashboardCite

Antineoplastics

2020
Reactions Weekly
0
0
0
0
View full textAdd to dashboardCite
scite logo

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product
Browser ExtensionAssistant by sciteCitation Statement SearchReference CheckVisualizationsDashboardsExplore JournalsExplore OrganizationsExplore FundersEmbedding BadgeEmbedding Citation SearchPricing
Resources
BlogHelp & FAQAccessibility StatementAPI TermsFor Universities & GovernmentsFor ResearchersFor PublishersFor Corporate, Pharma & EnterpriseAuthor MarketingBecome an AffiliateGet an organization trial or quotescite Data & Services
About
News & PressCareersRead our PaperCoverage

BlogTerms and ConditionsAPI TermsPrivacy PolicyContactCookie PreferencesDo Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.